REVIVE Webinar: Current developments in Clostridioides difficile prevention, therapy and R&D

Speakers:

• Benedikt Huttner, Unit Head – Research, Access, Stewardship and AMR surveillance, Department of Antimicrobial Resistance, World Health Organization (Switzerland)
• Paul Feuerstadt, Attending Physician, PACT Gastroenterology Center, Associate Clinical Professor of Medicine, Yale School of Medicine (USA)
• Kerrie Davies, Consultant Clinical Scientist, NIHR Leeds Biomedical Research Center (UK)
• Mark Wilcox, Professor of Medical Microbiology, University of Leeds (UK)

Moderator: Christian John Lillis, Chief Executive Officer, Peggy Lillis Foundation (USA)

• Presentation 1: Global epidemiology of C. Difficile and WHO priorities for prevention (Benedikt Huttner)
• Presentation 2: Pathophysiology of C difficile infection – implications for treatment (Paul Feurstadt)
• Presentation 3: Updates on diagnosis (Kerrie Davies) Presentation 4: Pipeline of new therapies (Mark Wilcox

Date and time:
Fri, Mar 13, 2026 5:00 PM – 6:30 PM CET

Dedicated registration link here